USFDA


  • Aug
    09
    By PTI

    Orchid Chemicals & Pharmaceuticals today said it has received US health regulator's approval to sell anti-epileptic levetiracetam tablets in the American market.

    The company has received approval from the US

  • May
    25
    By PTI

    Aurobindo Pharma said on Tuesday that it has received the nod from the US health regulator to manufacture and market its Valacyclovir Hydrochloride tablets, used for the treatment of chicken

  • May
    13
    By PTI

    Aurobindo Pharma today said it has received tentative approval of the US Food and Drug Administration (FDA) for the generic version of Crestor tablets used in the cardiovascular therapeutic area.

  • Apr
    10
    By PTI

    Sun Pharmaceutical Industries today announced that its US-based subsidiary has got tentative approval from the Food and Drug Administration to market a generic drug for the treatment of Alzheimer's disease.

  • Mar
    31
    By PTI

    Drug firm Glenmark today said US Food and Drug Administration (FDA) has accepted its new drug application for pain killer oxycodone hydrochloride capsules.
    "FDA in

  • Mar
    18
    By PTI

    Drug major Sun Pharma today said it has received approval from the US health regulator for generic version of anti-allergic product Prometh syrup.
    The United

  • Mar
    03
    By PTI

    Ranbaxy Laboratories today said it has failed to get the US health regulator's nod for launching generic version of Flomax, a prostrate drug, thereby missing the opportunity to launch the drug in America with exclusive marketing rights.

  • Feb
    25
    By PTI

    Aurobindo Pharma today said it has received a tentative approval from the US drug regulator for manufacturing and marketing of its Nevirapine tablets, used in the treatment of HIV infections.